Amphastar Pharmaceuticals (AMPH) Inventory (2013 - 2026)
Amphastar Pharmaceuticals (AMPH) posted quarterly Inventory of $170.2 million for Q1 2026, down 8.24% year-over-year from $185.5 million in Q1 2025, and down 3.79% quarter-over-quarter from $176.9 million in Q4 2025.
Amphastar Pharmaceuticals (AMPH) Inventory (2013 - 2026) Analysis & Trends
Amphastar Pharmaceuticals' Inventory history runs 14 years deep, the most recent figure standing at $170.2 million for Q1 2026.
- In Q1 2026, Inventory fell 8.24% year-over-year to $170.2 million; the TTM figure through Mar 2026 stood at $170.2 million (down 8.24% YoY), while the FY2025 annual figure was $176.9 million, up 15.06% from the prior year.
- Inventory for Q1 2026 stood at $170.2 million, down from $176.9 million in the prior quarter.
- The five-year high for Inventory was $191.7 million in Q2 2025, with the low at $95.1 million in Q1 2022.
- The 5-year median for Inventory is $115.5 million (2024), against an average of $132.8 million.
- The sharpest annual moves came in 2025 and 2026: Inventory surged 60.59% in 2025, then fell 8.24% in 2026.
- Amphastar Pharmaceuticals' Inventory stood at $103.6 million in 2022, then rose by 2.17% to $105.8 million in 2023, then surged by 45.27% to $153.7 million in 2024, then grew by 15.06% to $176.9 million in 2025, then decreased by 3.79% to $170.2 million in 2026.
- Business Quant data shows AMPH's Inventory at $170.2 million in Q1 2026, $176.9 million in Q4 2025, and $185.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 1.44 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 3.22 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 2.57 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 9.08 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 193.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 3.93 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 104.20 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 1.77 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 816.00 Mn |
| 10 | Amphastar Pharmaceuticals | 943.15 Mn | 653.02 Mn | 93.47 Mn | 179.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 179.91 Mn |
| Mar 31, 2026 | 170.19 Mn |
| Dec 31, 2025 | 176.89 Mn |
| Sep 30, 2025 | 185.93 Mn |
| Jun 30, 2025 | 191.73 Mn |
| Mar 31, 2025 | 185.48 Mn |
| Dec 31, 2024 | 153.74 Mn |
| Sep 30, 2024 | 130.32 Mn |
| Jun 30, 2024 | 122.41 Mn |
| Mar 31, 2024 | 115.49 Mn |
| Dec 31, 2023 | 105.83 Mn |
| Sep 30, 2023 | 109.98 Mn |
| Jun 30, 2023 | 104.62 Mn |
| Mar 31, 2023 | 103.65 Mn |
| Dec 31, 2022 | 103.58 Mn |
| Sep 30, 2022 | 103.25 Mn |
| Jun 30, 2022 | 98.73 Mn |
| Mar 31, 2022 | 95.15 Mn |
| Dec 31, 2021 | 92.81 Mn |
| Sep 30, 2021 | 100.24 Mn |